ZNTL – zentalis pharmaceuticals, inc. - common stock (US:NASDAQ)
Stock Stats
News
Zentalis Pharmaceuticals: Hanging On For One Last Shot At PROC Approval [Seeking Alpha]
Zentalis Pharmaceuticals (NASDAQ:ZNTL) was upgraded by analysts at Wall
Zentalis Pharmaceuticals (NASDAQ:ZNTL) had its price target lowered by analysts at Morgan Stanley from $8.00 to $4.00. They now have an "equal weight" rating on the stock.
Zentalis Pharmaceuticals (NASDAQ:ZNTL) had its "neutral" rating reaffirmed by analysts at Wedbush. They now have a $4.00 price target on the stock.
Zentalis Pharmaceuticals (NASDAQ:ZNTL) had its "market perform" rating reaffirmed by analysts at Leerink Partners.
Form SCHEDULE 13G Zentalis Pharmaceuticals Filed by: BARCLAYS PLC
Form 10-Q Zentalis Pharmaceuticals For: Sep 30
Form 8-K Zentalis Pharmaceuticals For: Nov 10
Form SCHEDULE 13G/A Zentalis Pharmaceuticals Filed by: MILLENNIUM MANAGEMENT LLC
Form 4 Zentalis Pharmaceuticals For: Oct 01 Filed by: Bucher James B
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.